文献速递心脑血管急症呼吸衰竭与机械通气

远期静脉血栓史与70岁后静脉血栓风险的关联

Association of Remote History of Venous Thrombosis With Risk of Venous Thrombosis After Age 70 Years.
PubMed 文献 · JAMA Netw Open · 2022-03-01
一句话结论70岁以上人群中,自报10年前以上的远期静脉血栓史与当前静脉血栓风险升高相关(OR 2.54,95%CI 1.56-4.13)。

该研究为2中心、基于人群的病例对照研究,纳入460例70岁及以上客观证实的静脉血栓患者和456例同地区随机对照,评估自报远期静脉血栓史(入组前>10年)与老年期静脉血栓风险的关联。结果显示,有远期静脉血栓史者发生静脉血栓的风险升高(OR 2.54;95%CI 1.56-4.13),且校正后及按时间分层(10-30年前OR 2.74;>30年前OR 2.42)均稳健。远期静脉血栓史的人群归因分数为7.7%。作者认为该量化结果可协助临床医生对患者进行静脉血栓预防建议。

要点

  • 70岁以上有远期静脉血栓史(>10年前)者,当前静脉血栓风险升高(OR 2.54;95%CI 1.56-4.13)。
  • 风险随时间推移仍持续:10-30年前发生静脉血栓者OR 2.74(95%CI 1.34-5.57),>30年前者OR 2.42(95%CI 1.21-4.84)。
  • 远期静脉血栓史的人群归因分数为7.7%。
  • 该关联在粗分析及校正后均稳健。

适用人群与场景

  • 70岁及以上、连续诊断且客观证实为静脉血栓(腿部深静脉血栓或肺栓塞)的患者,以及同地理区域随机选取的70岁及以上无静脉血栓对照个体。
  • 研究在美国伯灵顿和荷兰莱顿2个中心开展。

诊断标准与关键阈值

  • 暴露定义:自报远期静脉血栓,发生于入组前>10年。

研究设计与关键结果

  • 研究类型:2中心、基于人群的病例对照研究;2008年6月至2011年8月纳入460例静脉血栓患者和456例对照。
  • 人群特征:患者中女性60.2%(n=277),对照中女性52.4%(n=239);患者平均(范围)年龄78.7(70.0-100.9)岁,与对照相似。
  • 主要结果:与无远期静脉血栓者相比,有远期静脉血栓史者发生静脉血栓的风险升高(OR 2.54;95%CI 1.56-4.13)。
  • 时间分层:10-30年前发生静脉血栓者OR 2.74(95%CI 1.34-5.57);>30年前发生者OR 2.42(95%CI 1.21-4.84),风险均升高。
  • 远期静脉血栓史的人群归因分数为7.7%。

证据类型、等级与局限

  • 证据类型:病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,该风险量化结果可协助临床医生对老年患者进行静脉血栓预防建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Previous venous thrombosis (VT) is associated with risk of future VT, but quantification of risk over the life course is poorly understood. More information is needed for clinicians to understand the association of remote history of VT with the risk of VT in older patients.

OBJECTIVE: To assess the association between a remote history of VT and the development of VT in older age.

DESIGN, SETTING, AND PARTICIPANTS: The Age and Thrombosis, Acquired and Genetic Risk Factors in the Elderly case-control study enrolled patients 70 years and older with VT and control individuals 70 years and older without VT between June 2008 and August 2011. The Age and Thrombosis, Acquired and Genetic Risk Factors in the Elderly study is a 2-center, population-based case-control study that was conducted in Burlington, Vermont, in the US and in Leiden, the Netherlands. Consecutively diagnosed patients with an objectively proven episode of VT (deep vein thrombosis of the leg or pulmonary embolism) were included. Control individuals were identified in the same geographic areas as the patients and were randomly selected. Data were analyzed between May 2021 and October 2021.

EXPOSURES: Self-reported remote VT (occurring >10 years before to enrollment).

MAIN OUTCOMES AND MEASURES: The main outcome was the risk of VT at older age. The association of self-reported history of remote VT with VT at older age was assessed by calculating odds ratios (ORs) as estimates of relative risk with 95% CIs.

RESULTS: A total of 460 patients with VT and 456 control participants were included. There were slightly more women than men in both groups (60.2% of patients [n = 277] were women and 52.4% of control participants [n = 239] were women), and the mean (range) age of patients was 78.7 (70.0-100.9) years, which was similar to the control participants. Compared with individuals without remote VT, those with a remote history of VT had an increased risk of VT (OR, 2.54; 95% CI, 1.56-4.13). The crude risk estimate was robust to adjustment and time since remote VT, that is, individuals with a VT 10 to 30 years ago (OR, 2.74; 95% CI, 1.34-5.57) and those with a VT more than 30 years ago (OR, 2.42; 95% CI, 1.21-4.84) had a an increased risk of VT. The population-attributable fraction of a remote history of VT was 7.7%.

CONCLUSIONS AND RELEVANCE: In this study, a remote history of VT was associated with risk of VT in older individuals. This quantification could assist clinicians in advising patients on VT prevention.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Wang H, Cushman M, Rosendaal FR, et al. Association of Remote History of Venous Thrombosis With Risk of Venous Thrombosis After Age 70 Years. JAMA Netw Open. 2022. PMID: 35333359. doi:10.1001/jamanetworkopen.2022.4205

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。